Polymyositis
Neurology·MeSH: Myositis
Prevalence
5.0 / 100K
2 drugs in development·2 companies·4 clinical trials
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| vib7734 | Viela Bio, Inc. (VIE) |
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| kzr-616 | Kezar Life Sciences, Inc. (KZR) |
Compare drugs
Frequently asked questions
How many drugs are in development for Polymyositis?
BioSniper tracks 2 drugs in development for Polymyositis across 2 companies.
How many clinical trials target Polymyositis?
There are 4 clinical trials targeting Polymyositis tracked by BioSniper.
What is the prevalence of Polymyositis?
The estimated prevalence of Polymyositis is approximately 5.0 per 100,000 population.
Deep-dive into Polymyositis
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis